Data Integrity, ALCOA+ & Part 11 / Annex 11

Managing Shared Equipment and Instruments in a DI-Compliant Way Step-by-Step Guide to Managing Shared Equipment and Instruments with Data Integrity Compliance In pharmaceutical manufacturing environments within the US, UK, and EU, managing shared equipment and instruments in a manner compliant with data integrity (DI) principles is imperative. Regulatory bodies including the FDA, EMA, MHRA, PIC/S,…

Read More “Managing Shared Equipment and Instruments in a DI-Compliant Way” »

Managing Shared Equipment and Instruments in a DI-Compliant Way: A Step-by-Step GMP Tutorial Managing Shared Equipment and Instruments in a Data Integrity-Compliant Way Pharmaceutical manufacturing environments operating within the US, UK, and EU must ensure robust data integrity while managing shared equipment and instruments. Compliance with regulatory frameworks such as 21 CFR Part 11 in…

Read More “Managing Shared Equipment and Instruments in a DI-Compliant Way” »

Aligning Corporate and Site-Level Policies on Data Integrity Expectations Harmonizing Corporate and Site Policies for Robust Data Integrity Compliance In the pharmaceutical industry, maintaining data integrity throughout the manufacturing and quality processes is critical not only for product quality but for regulatory compliance across US, UK, and EU markets. Effective alignment between corporate-level strategic data…

Read More “Aligning Corporate and Site-Level Policies on Data Integrity Expectations” »

Managing DI in Multi-Language Documentation and Forms Step-by-Step Tutorial: Managing Data Integrity in Multi-Language Documentation and Forms for Pharma Compliance In today’s global pharmaceutical manufacturing and clinical environments, managing data integrity (DI) within multi-language documentation and forms is a critical regulatory and quality assurance requirement. With increasing complexity of global supply chains, multinational study sites,…

Read More “Managing DI in Multi-Language Documentation and Forms” »

Data Integrity Requirements for Printed Output, Labels and Attachments Data Integrity Requirements for Printed Output, Labels and Attachments in Pharma GMP Ensuring data integrity is a cornerstone of pharmaceutical Good Manufacturing Practice (GMP), especially when it comes to printed outputs, labels, and attachments. These physical and electronic records form the foundation of product release, traceability,…

Read More “Data Integrity Requirements for Printed Output, Labels and Attachments” »

Data Integrity Controls for Third-Party Applications Used in GMP Context Implementing Data Integrity Controls for Third-Party Applications in GMP Environments Pharmaceutical companies increasingly rely on third-party applications to support Good Manufacturing Practice (GMP) operations, including electronic batch records, laboratory information management systems (LIMS), and manufacturing execution systems (MES). While these systems offer functionality and efficiency,…

Read More “Data Integrity Controls for Third-Party Applications Used in GMP Context” »

Handling “Unknown User” and “System” Entries in Audit Trails: A Comprehensive Guide Step-by-Step Guide to Handling “Unknown User” and “System” Entries in Audit Trails for Pharmaceutical Data Integrity In pharmaceutical manufacturing and clinical operations regulated by 21 CFR Part 11, Annex 11, and various Good Manufacturing Practice (GMP) frameworks, maintaining robust data integrity within electronic…

Read More “Handling “Unknown User” and “System” Entries in Audit Trails” »

Building a Data Integrity Maturity Model and Roadmap for the Site How to Build a Data Integrity Maturity Model and Roadmap for Your Pharma Site Ensuring data integrity within pharmaceutical manufacturing sites is critical to maintain product quality, patient safety, and regulatory compliance. For professionals in pharma QA, regulatory affairs, clinical operations, and medical affairs,…

Read More “Building a Data Integrity Maturity Model and Roadmap for the Site” »

Major Data Integrity Failures: Case Studies and Regulatory Consequences Understanding Major Data Integrity Failures: Regulatory Impact and Compliance Strategies Data integrity stands as a pillar of Good Manufacturing Practice (GMP) compliance within pharmaceutical manufacturing and clinical operations. Ensuring trustworthy, accurate, and complete data underpins patient safety, product quality, and regulatory adherence. Over recent years, regulators…

Read More “Major Data Integrity Failures: Case Studies and Regulatory Consequences” »

Aligning DI Remediation With Corporate Digital and Automation Strategy Step-by-Step Guide to Aligning Data Integrity Remediation With Corporate Digital and Automation Strategies in Pharma In the ever-evolving pharmaceutical industry, ensuring data integrity is paramount to complying with regulatory requirements and maintaining patient safety. The integration of DI remediation into corporate digital and automation strategies has…

Read More “Aligning DI Remediation With Corporate Digital and Automation Strategy” »